Nplate 250 ug/.5mL
romiplostim · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Amgen, Inc
No Recall History
Plain English
Nplate is a injection, powder, lyophilized, for solution containing romiplostim at 250 ug/.5mL, taken subcutaneous. Manufactured by Amgen, Inc.
Key Facts
- Brand Name
- Nplate
- Generic Name
- romiplostim
- NDC Code (Product)
55513-221- Manufacturer
- Amgen, Inc
- Strength
- 250 ug/.5mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125268
- Drug Class
- Thrombopoietin Receptor Agonist [EPC]
- Marketing Start
- 08/25/2008
Recall History
No Recall HistoryFrequently Asked Questions
What is Nplate used for?
Nplate contains romiplostim. It is a injection, powder, lyophilized, for solution taken subcutaneous. Consult your doctor for specific uses.
Is Nplate a controlled substance?
Nplate is not classified as a controlled substance by the DEA.
What is the generic name for Nplate?
The generic name for Nplate is romiplostim. There are no other listed brand versions of romiplostim.
What is the NDC code for Nplate 250 ug/.5mL?
The NDC (National Drug Code) for Nplate 250 ug/.5mL is 55513-221, listed by Amgen, Inc.
Other Nplate Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)